Insider · CIK 0001946070
Joseph Michael Harris
Files at NEPH (NEPHROS INC). First filing -, latest -.
Joseph Michael Harris files SEC Form 4 as director at NEPH (NEPHROS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joseph Michael Harris has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | NEPH NEPHROS INC | AGrant or award Stock Option (right to buy)derivative | +7,050 | $0.00 | $0 | 7,050 | Jan 3, 2025 |
Questions about Joseph Michael Harris
Answered from the filings on this page, as of the latest one.
Is Joseph Michael Harris buying or selling?
Joseph Michael Harris has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joseph Michael Harris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Michael Harris has 0.
Where does Joseph Michael Harris file Form 4?
Joseph Michael Harris has filed Form 4 at NEPH (NEPHROS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.